Loncastuximab Tesirine,Polatuzumab Vedotin,Glofitamab,Mosunetuzumab,Obinutuzumab
overland adct biopharmaceuticals,mitsubishi tanabe,Roche,
['adctherap']
today: don't miss the poster presentation highlighting our ongoing lotis-7 #clinicaltrial evaluating our cd19-targeted #antibodydrugconjugate in combination with other anticancer agents at #asco23! 
Leading the development & commercialization of next-generation antibody drug conjugates with highly potent and targeted pyrrolobenzodiazepine dimer technology